Exact Mass: 489.1439

Exact Mass Matches: 489.1439

Found 182 metabolites which its exact mass value is equals to given mass value 489.1439, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

4-Hydroxy duloxetine glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-({4-[(1S)-3-(methylamino)-1-(thiophen-2-yl)propoxy]naphthalen-1-yl}oxy)oxane-2-carboxylic acid

C24H27NO8S (489.1457)


4-Hydroxy duloxetine glucuronide is a metabolite of duloxetine. Duloxetine (sold under the brand names Cymbalta, Ariclaim, Xeristar, Yentreve, Duzela) is a serotonin-norepinephrine reuptake inhibitor (SNRI) manufactured and marketed by Eli Lilly. It is effective for major depressive disorder and generalized anxiety disorder (GAD). (Wikipedia)

   

3-Benzyl-1-(1H-imidazol-4-ylmethyl)-4-(thien-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carbonitrile

3-benzyl-1-[(1H-imidazol-5-yl)methyl]-4-(thiophene-2-sulfonyl)-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carbonitrile

C25H23N5O2S2 (489.1293)


   

Gemigliptin

1-{2-amino-4-[2,4-bis(trifluoromethyl)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl]-4-oxobutyl}-5,5-difluoropiperidin-2-one

C18H19F8N5O2 (489.1411)


   

(2S)-3-[3-[(4-Carbamimidoylbenzoyl)amino]propanoylamino]-2-[(4-ethylphenyl)sulfonylamino]propanoic acid

3-({3-[(4-carbamimidoylphenyl)formamido]-1-hydroxypropylidene}amino)-2-(4-ethylbenzenesulphonamido)propanoic acid

C22H27N5O6S (489.1682)


   
   

O1-[2-(2-amino-4-oxo-3,4-dihydro-pteridin-6-yl)-1-(1,2,3-dihydroxy-propyl)-ethyl]-beta-D-glucopyranuronic acid

O1-[2-(2-amino-4-oxo-3,4-dihydro-pteridin-6-yl)-1-(1,2,3-dihydroxy-propyl)-ethyl]-beta-D-glucopyranuronic acid

C17H23N5O12 (489.1343)


   
   

N-(4-Acetamidophenyl)indomethacin Amide

N-(4-Acetamidophenyl)indomethacin Amide

C27H24ClN3O4 (489.1455)


   
   

dG-C8-PhIP_HCD_80_789

dG-C8-PhIP_HCD_80_789

C23H23N9O4 (489.1873)


   

8-2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-deoxyguanosine

8-2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-deoxyguanosine

C23H23N9O4 (489.1873)


   

Cys Cys His Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C18H31N7O5S2 (489.1828)


   

Cys Cys His Gln

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C17H27N7O6S2 (489.1464)


   

Cys Cys Lys His

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O5S2 (489.1828)


   

Cys Cys Gln His

(2S)-2-[(2S)-2-[(2R)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O6S2 (489.1464)


   

Cys His Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]hexanoic acid

C18H31N7O5S2 (489.1828)


   

Cys His Cys Gln

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C17H27N7O6S2 (489.1464)


   

Cys His Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-sulfanylpropanoic acid

C18H31N7O5S2 (489.1828)


   

Cys His Gln Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C17H27N7O6S2 (489.1464)


   

Cys Lys Cys His

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O5S2 (489.1828)


   

Cys Lys His Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C18H31N7O5S2 (489.1828)


   

Cys Gln Cys His

(2S)-2-[(2R)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O6S2 (489.1464)


   

Cys Gln His Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H27N7O6S2 (489.1464)


   

Asp Met Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C19H31N5O8S (489.1893)


   

Asp Met Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Asp Asn Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C17H27N7O10 (489.1819)


   

Asp Asn Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C17H27N7O10 (489.1819)


   

Asp Pro Met Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoic acid

C19H31N5O8S (489.1893)


   

Asp Pro Gln Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoic acid

C19H31N5O8S (489.1893)


   

Asp Gln Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Asp Gln Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C17H27N7O10 (489.1819)


   

Asp Gln Pro Met

(3S)-3-amino-3-{[(2S)-4-carbamoyl-1-[(2S)-2-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}pyrrolidin-1-yl]-1-oxobutan-2-yl]carbamoyl}propanoic acid

C19H31N5O8S (489.1893)


   

Glu Met Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Glu Met Pro Asn

(4S)-4-amino-4-{[(2S)-1-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-4-(methylsulfanyl)-1-oxobutan-2-yl]carbamoyl}butanoic acid

C19H31N5O8S (489.1893)


   

Glu Asn Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Glu Asn Asn Asn

(4S)-4-amino-4-{[(1S)-2-carbamoyl-1-{[(1S)-2-carbamoyl-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C17H27N7O10 (489.1819)


   

Glu Asn Pro Met

(4S)-4-amino-4-{[(2S)-3-carbamoyl-1-[(2S)-2-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}pyrrolidin-1-yl]-1-oxopropan-2-yl]carbamoyl}butanoic acid

C19H31N5O8S (489.1893)


   

Glu Pro Met Asn

(4S)-4-amino-5-[(2S)-2-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H31N5O8S (489.1893)


   

Glu Pro Asn Met

(4S)-4-amino-5-[(2S)-2-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}ethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H31N5O8S (489.1893)


   

His Cys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C18H31N7O5S2 (489.1828)


   

His Cys Cys Gln

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C17H27N7O6S2 (489.1464)


   

His Cys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C18H31N7O5S2 (489.1828)


   

His Cys Gln Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C17H27N7O6S2 (489.1464)


   

His Lys Cys Cys

(2R)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H31N7O5S2 (489.1828)


   

His Gln Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H27N7O6S2 (489.1464)


   

Lys Cys Cys His

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H31N7O5S2 (489.1828)


   

Lys Cys His Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C18H31N7O5S2 (489.1828)


   

Lys His Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C18H31N7O5S2 (489.1828)


   

Met Asp Pro Gln

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanoic acid

C19H31N5O8S (489.1893)


   

Met Asp Gln Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carboxypropanamido]-4-carbamoylbutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Met Glu Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carboxybutanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Met Glu Pro Asn

(4S)-4-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-5-[(2S)-2-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H31N5O8S (489.1893)


   

Met Asn Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Met Asn Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H31N5O8S (489.1893)


   

Met Pro Asp Gln

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-4-carbamoylbutanoic acid

C19H31N5O8S (489.1893)


   

Met Pro Glu Asn

(4S)-4-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C19H31N5O8S (489.1893)


   

Met Pro Asn Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]pentanedioic acid

C19H31N5O8S (489.1893)


   

Met Pro Gln Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-4-carbamoylbutanamido]butanedioic acid

C19H31N5O8S (489.1893)


   

Met Gln Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Met Gln Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C19H31N5O8S (489.1893)


   

Asn Asp Asn Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanoic acid

C17H27N7O10 (489.1819)


   

Asn Asp Gln Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanoic acid

C17H27N7O10 (489.1819)


   

Asn Glu Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carboxybutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Asn Glu Asn Asn

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-4-{[(1S)-2-carbamoyl-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}ethyl]carbamoyl}butanoic acid

C17H27N7O10 (489.1819)


   

Asn Glu Pro Met

(4S)-4-[(2S)-2-amino-3-carbamoylpropanamido]-5-[(2S)-2-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}pyrrolidin-1-yl]-5-oxopentanoic acid

C19H31N5O8S (489.1893)


   

Asn Met Glu Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-4-carboxybutanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Asn Met Pro Glu

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}pentanedioic acid

C19H31N5O8S (489.1893)


   

Asn Asn Asp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]-4-carbamoylbutanoic acid

C17H27N7O10 (489.1819)


   

Asn Asn Glu Asn

(4S)-4-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}butanoic acid

C17H27N7O10 (489.1819)


   

Asn Asn Asn Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]pentanedioic acid

C17H27N7O10 (489.1819)


   

Asn Asn Gln Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carbamoylpropanamido]-4-carbamoylbutanamido]butanedioic acid

C17H27N7O10 (489.1819)


   

Asn Pro Glu Met

(4S)-4-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C19H31N5O8S (489.1893)


   

Asn Pro Met Glu

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]pentanedioic acid

C19H31N5O8S (489.1893)


   

Asn Gln Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C17H27N7O10 (489.1819)


   

Asn Gln Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanamido]-3-carbamoylpropanamido]butanedioic acid

C17H27N7O10 (489.1819)


   

Pro Asp Met Gln

(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-(methylsulfanyl)butanamido]butanoic acid

C19H31N5O8S (489.1893)


   

Pro Asp Gln Met

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-3-carboxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-4-(methylsulfanyl)butanoic acid

C19H31N5O8S (489.1893)


   

Pro Glu Met Asn

(4S)-4-{[(1S)-1-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-3-(methylsulfanyl)propyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C19H31N5O8S (489.1893)


   

Pro Glu Asn Met

(4S)-4-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}ethyl]carbamoyl}-4-[(2S)-pyrrolidin-2-ylformamido]butanoic acid

C19H31N5O8S (489.1893)


   

Pro Met Asp Gln

(2S)-4-carbamoyl-2-[(2S)-3-carboxy-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]butanoic acid

C19H31N5O8S (489.1893)


   

Pro Met Glu Asn

(4S)-4-{[(1S)-2-carbamoyl-1-carboxyethyl]carbamoyl}-4-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanoic acid

C19H31N5O8S (489.1893)


   

Pro Met Asn Glu

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]pentanedioic acid

C19H31N5O8S (489.1893)


   

Pro Met Gln Asp

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]butanamido]butanedioic acid

C19H31N5O8S (489.1893)


   

Pro Asn Glu Met

(4S)-4-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}butanoic acid

C19H31N5O8S (489.1893)


   

Pro Asn Met Glu

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-4-(methylsulfanyl)butanamido]pentanedioic acid

C19H31N5O8S (489.1893)


   

Pro Gln Asp Met

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-carboxypropanamido]-4-(methylsulfanyl)butanoic acid

C19H31N5O8S (489.1893)


   

Pro Gln Met Asp

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-4-(methylsulfanyl)butanamido]butanedioic acid

C19H31N5O8S (489.1893)


   

Gln Cys Cys His

(2S)-2-[(2R)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C17H27N7O6S2 (489.1464)


   

Gln Cys His Cys

(2R)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-sulfanylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanoic acid

C17H27N7O6S2 (489.1464)


   

Gln Asp Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Gln Asp Asn Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]-3-carbamoylpropanoic acid

C17H27N7O10 (489.1819)


   

Gln Asp Pro Met

(3S)-3-[(2S)-2-amino-4-carbamoylbutanamido]-4-[(2S)-2-{[(1S)-1-carboxy-3-(methylsulfanyl)propyl]carbamoyl}pyrrolidin-1-yl]-4-oxobutanoic acid

C19H31N5O8S (489.1893)


   

Gln His Cys Cys

(2R)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-sulfanylpropanamido]-3-sulfanylpropanoic acid

C17H27N7O6S2 (489.1464)


   

Gln Met Asp Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanamido]-3-carboxypropanoyl]pyrrolidine-2-carboxylic acid

C19H31N5O8S (489.1893)


   

Gln Met Pro Asp

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}butanedioic acid

C19H31N5O8S (489.1893)


   

Gln Asn Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C17H27N7O10 (489.1819)


   

Gln Asn Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanamido]-3-carbamoylpropanamido]butanedioic acid

C17H27N7O10 (489.1819)


   

Gln Pro Asp Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-3-carboxypropanamido]-4-(methylsulfanyl)butanoic acid

C19H31N5O8S (489.1893)


   

Gln Pro Met Asp

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-carbamoylbutanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]butanedioic acid

C19H31N5O8S (489.1893)


   

N-(4-acetamidophenyl)-Indomethacin amide

N-(4-acetamidophenyl)-1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetamide

C27H24ClN3O4 (489.1455)


   

Tyr-Trp-OH

(S)-2-(3-(4-hydroxyphenethoxy)-4-nitrobenzamido)-3-(1H-indol-3-yl)propanoic acid

C26H23N3O7 (489.1536)


   

Trp-Tyr-OH

(S)-2-(3-(2-(1H-indol-3-yl)ethoxy)-4-nitrobenzamido)-3-(4-hydroxyphenyl)propanoic acid

C26H23N3O7 (489.1536)


   

Diacylglycerol kinase inhibitor II

Diacylglycerol kinase inhibitor II

C28H25F2N3OS (489.1686)


   

BMS 214662

7-cyano-2,3,4,5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3-(phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine

C25H23N5O2S2 (489.1293)


C471 - Enzyme Inhibitor > C2020 - Farnesyl Transferase Inhibitor

   

5-chloro-2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium methyl sulphate

5-chloro-2-[2-[4-[(2-cyanoethyl)methylamino]phenyl]vinyl]-1,3,3-trimethyl-3H-indolium methyl sulphate

C24H28ClN3O4S (489.1489)


   

Talmetacin

Talmetacin

C27H20ClNO6 (489.0979)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

3-BENZYL-1,4,5-TRIPHENYLIMIDAZOLIUM PERCHLORATE

3-BENZYL-1,4,5-TRIPHENYLIMIDAZOLIUM PERCHLORATE

C28H26ClN2O4 (489.1581)


   
   

1,2,4-Benzotriazin-3-amine, 7-(2-chloro-5-Methoxyphenyl)-5-Methyl-N-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-

1,2,4-Benzotriazin-3-amine, 7-(2-chloro-5-Methoxyphenyl)-5-Methyl-N-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-

C27H28ClN5O2 (489.1931)


   

1-Octyl-2,3-dimethylimidazolium bis(trifluoromethanesulfonyl)imide

1-Octyl-2,3-dimethylimidazolium bis(trifluoromethanesulfonyl)imide

C15H25F6N3O4S2 (489.1191)


   

3-(3-amino-3-oxopropyl)-2-[[1-methyl-2-(p-tolyl)-1H-indol-3-yl]azo]benzothiazolium chloride

3-(3-amino-3-oxopropyl)-2-[[1-methyl-2-(p-tolyl)-1H-indol-3-yl]azo]benzothiazolium chloride

C26H24ClN5OS (489.139)


   
   

(S)-AMINO-(3-NITRO-PHENYL)-ACETICACID

(S)-AMINO-(3-NITRO-PHENYL)-ACETICACID

C21H22F3NO7S (489.1069)


   

2-(4-METHYLUMBELLIFERYL)-α-D-N-ACETYLNEURAMINIC ACID SODIUM SALT

2-(4-METHYLUMBELLIFERYL)-α-D-N-ACETYLNEURAMINIC ACID SODIUM SALT

C21H24NNaO11 (489.1247)


   
   

[(2R)-1-[6-(propan-2-yloxycarbonylamino)purin-9-yl]propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphinic acid

[(2R)-1-[6-(propan-2-yloxycarbonylamino)purin-9-yl]propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphinic acid

C18H28N5O9P (489.1625)


   
   

tert-Butyl (2S,5S)-2-(9-chloro-1,11-dihydroisochromeno[4,3:6,7]naphtho[1,2-d]imidazol-2-yl)-5-(methyl)pyrrolidine-1-carboxylate

tert-Butyl (2S,5S)-2-(9-chloro-1,11-dihydroisochromeno[4,3:6,7]naphtho[1,2-d]imidazol-2-yl)-5-(methyl)pyrrolidine-1-carboxylate

C28H28ClN3O3 (489.1819)


   

Gemigliptin

Gemigliptin

C18H19F8N5O2 (489.1411)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BH - Dipeptidyl peptidase 4 (dpp-4) inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98086 - Dipeptidyl Peptidase-4 Inhibitor C471 - Enzyme Inhibitor > C783 - Protease Inhibitor

   

PRX-07034 hydrochloride

PRX-07034 hydrochloride

C21H29Cl2N3O4S (489.1256)


PRX-07034 hydrochloride is a highly selective and potent 5-HT6 receptor antagonist with a Ki= 4-8 nM and an IC50 of 19 nM. PRX-07034 can be used for the research of enhancing working memory and cognitive flexibility[1].

   

(2S,3S,4R,5R)-2-(5-tert-Butyl-1,3,4-oxadiazol-2-yl)-5-(6-(4-chloro-2-fluoro-anilino)purin-9-yl)tetrahydrofuran-3,4-diol

(2S,3S,4R,5R)-2-(5-tert-Butyl-1,3,4-oxadiazol-2-yl)-5-(6-(4-chloro-2-fluoro-anilino)purin-9-yl)tetrahydrofuran-3,4-diol

C21H21ClFN7O4 (489.1328)


   

1-((1H-Imidazol-5-yl)methyl)-3-benzyl-4-(thiophen-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonitrile

1-((1H-Imidazol-5-yl)methyl)-3-benzyl-4-(thiophen-2-ylsulfonyl)-2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepine-7-carbonitrile

C25H23N5O2S2 (489.1293)


   

4-Hydroxy Duloxetine b-D-Glucuronide

4-Hydroxy Duloxetine b-D-Glucuronide

C24H27NO8S (489.1457)


   
   
   

5-(benzenesulfonyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-ethylbenzenesulfonamide

5-(benzenesulfonyl)-N-[2-(3,4-dimethoxyphenyl)ethyl]-2-ethylbenzenesulfonamide

C24H27NO6S2 (489.128)


   

N-[4-bromo-2-[[(2-hydrazinyl-2-oxoethyl)amino]-phenylmethyl]phenyl]-3-(4-morpholinyl)propanamide

N-[4-bromo-2-[[(2-hydrazinyl-2-oxoethyl)amino]-phenylmethyl]phenyl]-3-(4-morpholinyl)propanamide

C22H28BrN5O3 (489.1375)


   

[9-(4-Ethoxyphenyl)sulfonyl-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl]-(4-methylphenyl)methanone

[9-(4-Ethoxyphenyl)sulfonyl-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-yl]-(4-methylphenyl)methanone

C27H23NO6S (489.1246)


   
   

2-[5-Methanesulfonylamino-2-(4-aminophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-n-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl)acetamide

2-[5-Methanesulfonylamino-2-(4-aminophenyl)-6-oxo-1,6-dihydro-1-pyrimidinyl]-n-(3,3,3-trifluoro-1-isopropyl-2-oxopropyl)acetamide

C19H22F3N5O5S (489.1294)


   

Citicoline

{[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[2-(trimethylazaniumyl)ethoxy]phosphoryl}oxy)phosphinic acid

C14H27N4O11P2+ (489.1152)


Citicoline is an essential intermediate in the biosynthetic pathway of structural phospholipids in cell membranes, particularly phosphatidylcholine. Once absorbed, citicoline is widely distributed throughout the body, crosses the blood-brain barrier and reaches the central nervous system (CNS), where it is incorporated into the membrane and microsomal phospholipid fraction. Citicoline activates biosynthesis of structural phospholipids of neuronal membranes, increases brain metabolism, and acts upon the levels of different neurotransmitters. Thus, citicoline has been experimentally shown to increase norepinephrine and dopamine levels in the CNS. Owing to these pharmacological mechanisms, citicoline has a neuroprotective effect in hypoxic and ischemic conditions, decreasing the volume of ischemic lesion, and also improves learning and memory performance in animal models of brain aging. In addition, citicoline has been shown to restore the activity of mitochondrial ATPase and membrane Na+/K+ATPase, to inhibit activation of certain phospholipases, and to accelerate reabsorption of cerebral edema in various experimental models. Citicoline has also been shown to be able to inhibit mechanisms of apoptosis associated to cerebral ischemia and in certain neurodegeneration models, and to potentiate neuroplasticity mechanisms. Citicoline is a safe drug, as shown by the toxicological tests conducted, that has no significant systemic cholinergic effects and is a well tolerated product. (PMID: 17171187) [HMDB]. Citicoline is found in many foods, some of which are chives, black walnut, kohlrabi, and abiyuch. Citicoline is an essential intermediate in the biosynthetic pathway of structural phospholipids in cell membranes, particularly phosphatidylcholine. Once absorbed, citicoline is widely distributed throughout the body, crosses the blood-brain barrier and reaches the central nervous system (CNS), where it is incorporated into the membrane and microsomal phospholipid fraction. Citicoline activates biosynthesis of structural phospholipids of neuronal membranes, increases brain metabolism, and acts upon the levels of different neurotransmitters. Thus, citicoline has been experimentally shown to increase norepinephrine and dopamine levels in the CNS. Owing to these pharmacological mechanisms, citicoline has a neuroprotective effect in hypoxic and ischemic conditions, decreasing the volume of ischemic lesion, and also improves learning and memory performance in animal models of brain aging. In addition, citicoline has been shown to restore the activity of mitochondrial ATPase and membrane Na+/K+ATPase, to inhibit activation of certain phospholipases, and to accelerate reabsorption of cerebral edema in various experimental models. Citicoline has also been shown to be able to inhibit mechanisms of apoptosis associated to cerebral ischemia and in certain neurodegeneration models, and to potentiate neuroplasticity mechanisms. Citicoline is a safe drug, as shown by the toxicological tests conducted, that has no significant systemic cholinergic effects and is a well tolerated product. (PMID:17171187). N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics D002491 - Central Nervous System Agents > D018697 - Nootropic Agents

   

(2R,3R,4S,7S)-7-(2-bromo-5-hydroxyphenyl)-3-[(3R,4R)-3,4-dihydroxypentanoyl]oxy-7-methoxy-2,4-dimethylheptanoate

(2R,3R,4S,7S)-7-(2-bromo-5-hydroxyphenyl)-3-[(3R,4R)-3,4-dihydroxypentanoyl]oxy-7-methoxy-2,4-dimethylheptanoate

C21H30BrO8- (489.1124)


   

4-Amino-1-{5-O-[hydroxy({hydroxy[2-(trimethylazaniumyl)ethoxy]phosphoryl}oxy)phosphoryl]pentofuranosyl}pyrimidin-2(1H)-one

4-Amino-1-{5-O-[hydroxy({hydroxy[2-(trimethylazaniumyl)ethoxy]phosphoryl}oxy)phosphoryl]pentofuranosyl}pyrimidin-2(1H)-one

C14H27N4O11P2+ (489.1152)


   

(2S)-3-[3-[(4-Carbamimidoylbenzoyl)amino]propanoylamino]-2-[(4-ethylphenyl)sulfonylamino]propanoic acid

(2S)-3-[3-[(4-Carbamimidoylbenzoyl)amino]propanoylamino]-2-[(4-ethylphenyl)sulfonylamino]propanoic acid

C22H27N5O6S (489.1682)


   

4-[(2-bromophenoxy)methyl]-N-[4-[(3,5-dimethyl-1-pyrazolyl)methyl]phenyl]benzamide

4-[(2-bromophenoxy)methyl]-N-[4-[(3,5-dimethyl-1-pyrazolyl)methyl]phenyl]benzamide

C26H24BrN3O2 (489.1052)


   

FluorX 5-isomer

FluorX 5-isomer

C27H23NO8 (489.1424)


   

4-[[3-[(4-Chlorophenyl)sulfonylamino]-2-quinoxalinyl]amino]-1-piperidinecarboxylic acid ethyl ester

4-[[3-[(4-Chlorophenyl)sulfonylamino]-2-quinoxalinyl]amino]-1-piperidinecarboxylic acid ethyl ester

C22H24ClN5O4S (489.1237)


   

N-(3-hydroxyphenyl)-2-[[4-methyl-5-[4-(4-morpholinylsulfonyl)phenyl]-1,2,4-triazol-3-yl]thio]acetamide

N-(3-hydroxyphenyl)-2-[[4-methyl-5-[4-(4-morpholinylsulfonyl)phenyl]-1,2,4-triazol-3-yl]thio]acetamide

C21H23N5O5S2 (489.1141)


   

3-[[4-(1-benzotriazolyl)-1-piperidinyl]sulfonyl]-N-cyclopentylbenzenesulfonamide

3-[[4-(1-benzotriazolyl)-1-piperidinyl]sulfonyl]-N-cyclopentylbenzenesulfonamide

C22H27N5O4S2 (489.1504)


   

4-[3-[(3-chloro-4-fluoroanilino)-oxomethyl]-7-oxo-1H-pyrazolo[1,5-a]pyrimidin-5-yl]-1-piperidinecarboxylic acid tert-butyl ester

4-[3-[(3-chloro-4-fluoroanilino)-oxomethyl]-7-oxo-1H-pyrazolo[1,5-a]pyrimidin-5-yl]-1-piperidinecarboxylic acid tert-butyl ester

C23H25ClFN5O4 (489.1579)


   

1-[(4-chlorophenyl)-oxomethyl]-N-[4-(1-piperidinylsulfonyl)phenyl]-3-piperidinecarboxamide

1-[(4-chlorophenyl)-oxomethyl]-N-[4-(1-piperidinylsulfonyl)phenyl]-3-piperidinecarboxamide

C24H28ClN3O4S (489.1489)


   

2-[(5-anilino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide

2-[(5-anilino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide

C21H23N5O3S3 (489.0963)


   

FluorX 6-isomer

FluorX 6-isomer

C27H23NO8 (489.1424)


   

N-[[3-(4-carboxybutyl)-5-chloro-3,4-dihydro-8-hydroxy-1-oxo-1H-2-benzopyran-7-yl]carbonyl]-L-phenylalanine

N-[[3-(4-carboxybutyl)-5-chloro-3,4-dihydro-8-hydroxy-1-oxo-1H-2-benzopyran-7-yl]carbonyl]-L-phenylalanine

C24H24ClNO8 (489.119)


   

(1R,9S,10S,11S)-5-(3-fluorophenyl)-10-(hydroxymethyl)-12-methylsulfonyl-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

(1R,9S,10S,11S)-5-(3-fluorophenyl)-10-(hydroxymethyl)-12-methylsulfonyl-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C24H28FN3O5S (489.1734)


   

(1S,9R,10R,11R)-5-(3-fluorophenyl)-10-(hydroxymethyl)-12-methylsulfonyl-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

(1S,9R,10R,11R)-5-(3-fluorophenyl)-10-(hydroxymethyl)-12-methylsulfonyl-11-(piperidine-1-carbonyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one

C24H28FN3O5S (489.1734)


   

4-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

4-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

C24H28FN3O5S (489.1734)


   

4-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

4-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

C24H28FN3O5S (489.1734)


   

[(3aR,4R,9bR)-1-(3-methoxyphenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol

[(3aR,4R,9bR)-1-(3-methoxyphenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol

C27H27N3O4S (489.1722)


   

[(3aS,4S,9bS)-1-(3-methoxyphenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol

[(3aS,4S,9bS)-1-(3-methoxyphenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol

C27H27N3O4S (489.1722)


   

(6R,7R,8R)-N-(2,5-difluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7R,8R)-N-(2,5-difluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C28H25F2N3O3 (489.1864)


   

(6S,7S,8S)-N-(2,5-difluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7S,8S)-N-(2,5-difluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C28H25F2N3O3 (489.1864)


   

N-[[(2R,3S)-8-[2-(3-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide

N-[[(2R,3S)-8-[2-(3-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide

C24H28FN3O5S (489.1734)


   

4-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

4-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

C24H28FN3O5S (489.1734)


   

4-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

4-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

C24H28FN3O5S (489.1734)


   

4-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

4-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

C24H28FN3O5S (489.1734)


   

4-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

4-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

C24H28FN3O5S (489.1734)


   

4-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

4-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

C24H28FN3O5S (489.1734)


   

4-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

4-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]benzenesulfonamide

C24H28FN3O5S (489.1734)


   

[(3aS,4R,9bS)-1-(3-methoxyphenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol

[(3aS,4R,9bS)-1-(3-methoxyphenyl)sulfonyl-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol

C27H27N3O4S (489.1722)


   

(6R,7S,8S)-N-(2,5-difluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6R,7S,8S)-N-(2,5-difluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C28H25F2N3O3 (489.1864)


   

(6S,7R,8R)-N-(2,5-difluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

(6S,7R,8R)-N-(2,5-difluorophenyl)-8-(hydroxymethyl)-2-oxo-7-[4-[(E)-2-phenylethenyl]phenyl]-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C28H25F2N3O3 (489.1864)


   
   

[(2R,3S,4R,5R)-5-[2-amino-5-[[[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino]methyl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,3S,4R,5R)-5-[2-amino-5-[[[(1S,4S,5R)-4,5-dihydroxycyclopent-2-en-1-yl]amino]methyl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C17H24N5O10P (489.1261)


   
   
   

JNJ-42226314

JNJ-42226314

C26H24FN5O2S (489.1635)


JNJ-42226314 is a competitive, highly selective and reversible non-covalent monoacylglycerol lipase (MAGL) inhibitor. JNJ-42226314 demonstrates dose-dependent enhancement of the major endocannabinoid 2-arachidonoylglycerol (2-AG) as well as efficacy in models of neuropathic and inflammatory pain[1].

   

3,4,5-trihydroxy-6-{[1,3,4,5-tetrahydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)pentan-2-yl]oxy}oxane-2-carboxylic acid

3,4,5-trihydroxy-6-{[1,3,4,5-tetrahydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)pentan-2-yl]oxy}oxane-2-carboxylic acid

C17H23N5O12 (489.1343)


   

methyl 4-[(7s)-7-(acetyloxy)-5-chloro-3-[(5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoate

methyl 4-[(7s)-7-(acetyloxy)-5-chloro-3-[(5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoate

C26H32ClNO6 (489.1918)


   

(2e)-3-(4-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid

(2e)-3-(4-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid

C28H27NO7 (489.1787)


   

Cytidine 5'-diphosphocholine sodium salt dihydrate

Cytidine 5'-diphosphocholine sodium salt dihydrate

C14H27N4O11P2+ (489.1152)


   

3-(4-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid

3-(4-{[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid

C28H27NO7 (489.1787)


   

(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(1r,2s,3r,4r)-1,3,4,5-tetrahydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)pentan-2-yl]oxy}oxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(1r,2s,3r,4r)-1,3,4,5-tetrahydroxy-1-(4-hydroxy-2-imino-1h-pteridin-6-yl)pentan-2-yl]oxy}oxane-2-carboxylic acid

C17H23N5O12 (489.1343)


   

(2z)-3-(4-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid

(2z)-3-(4-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}-3-methoxyphenyl)-n-[2-(4-hydroxyphenyl)ethyl]prop-2-enimidic acid

C28H27NO7 (489.1787)


   

methyl 4-[(7r)-7-(acetyloxy)-5-chloro-3-[(5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoate

methyl 4-[(7r)-7-(acetyloxy)-5-chloro-3-[(5s)-3,5-dimethylhepta-1,3-dien-1-yl]-7-methyl-6,8-dioxoisoquinolin-2-yl]butanoate

C26H32ClNO6 (489.1918)


   

2-(hydroxymethyl)-6-[(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-1h-indol-3-yl)oxy]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[(2-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-1h-indol-3-yl)oxy]oxane-3,4,5-triol

C20H27NO11S (489.1305)


   

2-({1-hydroxy-2-[(2r)-2-hydroxy-n-methyl-3-phenylpropanamido]ethylidene}amino)-n-[2-(methoxycarbonyl)phenyl]benzenecarboximidic acid

2-({1-hydroxy-2-[(2r)-2-hydroxy-n-methyl-3-phenylpropanamido]ethylidene}amino)-n-[2-(methoxycarbonyl)phenyl]benzenecarboximidic acid

C27H27N3O6 (489.19)


   

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-1h-indol-3-yl)oxy]oxane-3,4,5-triol

(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-[(2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-1h-indol-3-yl)oxy]oxane-3,4,5-triol

C20H27NO11S (489.1305)


   

(4ar,6s,7r,7as)-7-[(2-{[(2s,3s)-2-amino-1-hydroxy-3-methylpentylidene]aminosulfonyl}-1-hydroxyethylidene)amino]-6-hydroxy-4-(c-hydroxycarbonimidoyl)-2-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyridine-7-carboxylic acid

(4ar,6s,7r,7as)-7-[(2-{[(2s,3s)-2-amino-1-hydroxy-3-methylpentylidene]aminosulfonyl}-1-hydroxyethylidene)amino]-6-hydroxy-4-(c-hydroxycarbonimidoyl)-2-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyridine-7-carboxylic acid

C19H31N5O8S (489.1893)


   

7-({2-[(2-amino-1-hydroxy-3-methylpentylidene)aminosulfonyl]-1-hydroxyethylidene}amino)-6-hydroxy-4-(c-hydroxycarbonimidoyl)-2-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyridine-7-carboxylic acid

7-({2-[(2-amino-1-hydroxy-3-methylpentylidene)aminosulfonyl]-1-hydroxyethylidene}amino)-6-hydroxy-4-(c-hydroxycarbonimidoyl)-2-methyl-1h,4ah,5h,6h,7ah-cyclopenta[c]pyridine-7-carboxylic acid

C19H31N5O8S (489.1893)